Resources

Evolution of the Cell and Gene Therapy Sector: Takeaways From a Scientific Workshop

ARM Testimony to House Appropriations Committee on FY27 Funding

Q1 2026 Cell & Gene Therapy Sector Snapshot

A recap of the notable cell and gene therapy clinical, regulatory, and investment trends from Q1 2026.

ARM Statement to Senate Aging Committee for Hearing on FDA and Rare Diseases

ARM Comments on OIG's Solicitation of Proposals for New and Modified Safe Harbors

ARM Comments on CMMI's Proposed Global Benchmark for Efficient Drug Pricing (GLOBE) Model

Q4 2025 Cell & Gene Therapy Sector Snapshot

A recap of the notable cell and gene therapy clinical, regulatory, and investment trends from Q4 2025.

Invisible but Critical: Managing Process Residuals in Cell Therapies

ARM Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and the Accelerating Kids Access to Care Act

ARM Reasons to Believe in Cell and Gene Therapy Analysis: January 2025

Unique insights for investors seeking a better understanding of the CGT growth story.